XPO1 and B-cell chronic lymphocytic leukemia: Overexpression of XPO1 is associated with poor prognosis in solid tumor cancers, while single-point mutations have been identified and associated with Hodgkin’s lymphoma and chronic lymphocytic leukemia (CLL) [26].